Chronic inflammation – inflammaging – in the ageing cochlea: A novel target for future presbycusis therapy
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Chronic, low-grade inflammation, or inflammaging, is a crucial contributor to various age-related pathologies and natural processes in aging tissue, including the nervous system. Over the past two decades, much effort has been done to understand the mechanisms of inflammaging in disease models such as type II diabetes, cardiovascular disease, Alzheimer’s disease, Parkinson’s disease, and others. However, despite being the most prevalent neurodegenerative disorder, the number one communication disorder, and one of the top three chronic medical conditions of our aged population; little research has been conducted on the potential role of inflammation in age-related hearing loss (ARHL). Recently, it has been suggested that there is an inflammatory presence in the cochlea, perhaps involving diffusion processes of the blood-brain barrier as it relates to the inner ear. Recent research has found correlations between hearing loss and markers such as C-reactive protein, IL-6, and TNF-α indicating inflammatory status in human case-cohort studies. However, there have been very few reports of in vivo research investigating the role of chronic inflammation’s in hearing loss in the aging cochlea. Future research directed at better understanding the mechanisms of inflammation in the cochlea as well as the natural changes acquired with aging may provide a better understanding of how this process can accelerate presbycusis. Animal model experimentation and pre-clinical studies designed to recognize and characterize cochlear inflammatory mechanisms may suggest novel treatment strategies for preventing or treating ARHL. In this review, we seek to summarize key research in chronic inflammation, discuss its implications for possible roles in ARHL, and finally suggest directions for future investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · cited 1×
“Various further investigations have added this line of research (Koenig et al., 1999; Osiecki, 2004; Bermudez et al., 2002; Pearson et al., 2003; Blake and Ridker, 2002).”
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 3×
“Ridker et al. (2000) (human, plasma); Koenig et al. (1999) (human, serum); Bermudez et al. (2002) (human, whole blood); Blake and Ridker (2002) (human, plasma) Alzheimer’s Disease Age-related conditions associated with Alzheimer’s Disease suggest that chronic neuro-inflammatory mechanisms as well…”
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170 · cited 3×
“Dandona et al. (2004) (human, plasma); Duncan et al. (2003) (human, plasma); Kubaszek et al. (2003) (human, plasma); Pradhan et al. (2001) (human, plasma); Schmidt et al. (1999) (human, whole blood); Barzilay et al. (2001) (human, plasma); Han et al. (2002) (human, whole blood); Larsen et al.…”
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · cited 1×
“Blasko et al. (2004) (human, brain tissue); Walker et al. (2009) (human, brain tissue); Heppner et al. (2015) (Review); McGeer and McGeer (2003) (Review) Frailty Syndrome Frailty among elderly individuals has been shown to worsen with an increased chronic inflammatory state.”
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094 · cited 2×
“There is some evidence, however, that NF-κB regulates its expression levels (Bradley, 2008).”
Proinflammatory Cytokines, Aging, and Age-Related Diseases
Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., & Nourhashemi, F. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.009 · Cited by 1,094 · cited 2×
“sist of similar proteins and molecular mechanisms (Michaud et al., 2013).”
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946
Walston, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.20.2333 · Cited by 940 · cited 1×
“Baylis et al. (2013) (human, serum); Leng et al. (2007) (human, serum); Walston et al. (2002) (human, whole blood) Parkinson’s Disease Pro-inflammatory markers such as IL-1β, IL-6, and TNF-α are higher in both the brain and blood serum in Parkinson’s patients when compared to a healthy group.”
Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855
Gruver, A., Hudson, L., & Sempowski, G. (2007) · The Journal of Pathology · doi:10.1002/path.2104 · Cited by 834 · cited 1×
“This inflammaging process is the phenomenon of immunosenescence, including the normal fluctuations resulting from an aging immune system (Gruver et al., 2007).”
Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L.-C., Goode, J., Miething, C., Göktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.009 · Cited by 616
Inflammation and frailty in older women
Leng, S. X., Xue, Q., Tian, J., Walston, J. D., & Fried, L. P. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01186.x · Cited by 425 · cited 1×
“Baylis et al. (2013) (human, serum); Leng et al. (2007) (human, serum); Walston et al. (2002) (human, whole blood) Parkinson’s Disease Pro-inflammatory markers such as IL-1β, IL-6, and TNF-α are higher in both the brain and blood serum in Parkinson’s patients when compared to a healthy group.”
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., & Mandrup-Poulsen, T. (2009) · Diabetes Care · doi:10.2337/dc09-0533 · Cited by 401 · cited 1×
“…(2001) (human, plasma); Schmidt et al. (1999) (human, whole blood); Barzilay et al. (2001) (human, plasma); Han et al. (2002) (human, whole blood); Larsen et al. (2009) (human, whole blood) Cardiovascular Disease Pro-inflammatory markers, specifically CRP, play a critical role in the long term…”
Blasko, I., Stampfer‐Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., & Grubeck‐Loebenstein, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00101.x · Cited by 374
Zhang, W., Dai, M., Fridberger, A., Hassan, A., DeGagne, J., Neng, L., Zhang, F., He, W., Ren, T., Trune, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205210109 · Cited by 236 · cited 1×
“Research has suggested that PVM/Ms have the capability to regulate the permeability of the intrastrial fluid-blood barrier (Zhang et al., 2012).”
Nesto, R. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01296.x · Cited by 140
Fujioka, M., Okano, H., & Ogawa, K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00287 · Cited by 134
Cited by
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
A human circulating immune cell landscape in aging and COVID-19
Zheng, Y., Liu, X., Le, W., Xie, L., Li, H., Wen, W., Wang, S., Ma, S., Huang, Z., Ye, J., et al. (2020) · Protein & Cell · doi:10.1007/s13238-020-00762-2 · Cited by 270
Metadata
- Authors
- Watson, N., Ding, B., Zhu, X., & Frisina, R. D.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 40
- Pages
- 142-148
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W2763516532
- Cited by
- 210
- References
- 21
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.